within Pharmacolibrary.Drugs.ATC.S;

model S01EE03
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 2.5e-05,
    adminDuration  = 600,
    adminMass      = 0.03 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00067,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01EE03</td></tr><td>route:</td><td>ophthalmic</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Bimatoprost is a synthetic prostamide analog used primarily to reduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It is approved for ophthalmic use and is widely prescribed today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following topical ocular administration.</p><h4>References</h4><ol><li><p>Shafiee, A, et al., &amp; Hosseini, K (2013). Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes. <i>Clinical ophthalmology (Auckland, N.Z.)</i> 7 1549–1556. DOI:<a href=\"https://doi.org/10.2147/OPTH.S48766\">10.2147/OPTH.S48766</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23940414/\">https://pubmed.ncbi.nlm.nih.gov/23940414</a></p></li><li><p>Shen, J, et al., &amp; Attar, M (2017). Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications. <i>Clinical ophthalmology (Auckland, N.Z.)</i> 11 1761–1767. DOI:<a href=\"https://doi.org/10.2147/OPTH.S143428\">10.2147/OPTH.S143428</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29026287/\">https://pubmed.ncbi.nlm.nih.gov/29026287</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01EE03;
